1.	Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer Phase: Phase III Type: Treatment Status: Closed Age: 20 to 80 Sponsor: Other Protocol IDs: HGCSG-CAD, NCT00209742
2.	A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF) Phase: Phase III Type: Treatment Status: Closed Age: 20 to 75 Sponsor: Other Protocol IDs: JCOG-0205-MF, C000000193, NCT00190515
3.	Phase III Randomized Study of Adjuvant Chemotherapy Comprising S-1 Versus Tegafur-Uracil (UFT) in Patients With Definitively Treated Stage III or IV Squamous Cell Carcinoma of the Head and Neck. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: 20 to 75 Sponsor: Other Protocol IDs: YCU-BRI-HN-05-01, NCT00336947
4.	Phase III Randomized Study of Adjuvant Tegafur-Uracil Versus Observation Only in Patients With Curatively Resected Stage II Colorectal Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Treatment Status: Closed Age: 20 to 80 Sponsor: Other Protocol IDs: TMDU-BRI-CC-05-01, NCT00392899
5.	A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer Phase: Phase III Type: Treatment Status: Closed Age: 20 to 80 Sponsor: Other Protocol IDs: MCSGO-CCTG-0501, NCT00385970
6.	Phase III Randomized Study of Adjuvant Tegafur-Uracil and Leucovorin Calcium Versus S-1 in Patients With Resected Stage III Colon Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 20 to 80 Sponsor: Other Protocol IDs: TMDU-TRICC0706, TRICC0706, NCT00660894
7.	Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: COLOCROSS, NCT00905047
8.	Phase II Study with UFT Plus Leucovorin Calcium for Metastatic Gastric Cancer (Summary Last Modified 09/98) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: EORTC-16964G
9.	Phase II Randomized Study of Oral Fluorouracil-uracil and Leucovorin Calcium Versus Intravenous Fluorouracil and Leucovorin Calcium in Patients with Previously Untreated Advanced Colorectal Cancer (Summary Last Modified 12/1999) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: EORTC-16966C
10.	Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer Phase: Phase II Type: Treatment Status: Completed Age: 75 and over Sponsor: NCI, Other Protocol IDs: CDR0000067511, E-1299, NCT00004860
11.	A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 to 79 Sponsor: Other Protocol IDs: BMS-200604, UMCC 0110g, NCT00037089
12.	Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab. Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: EMR200025-001, NCT00439517
13.	Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: 950914, NCT00464919
14.	UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: 940813, TTY-TU0510, NCT00519688
15.	Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer Phase: Phase II Type: Treatment Status: Temporarily closed Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: TRIBC1009, NCT01262274
16.	Phase I Pilot Study of Postoperative Oral Fluorouracil-Uracil Plus Leucovorin Calcium Concurrently With Radiotherapy in Patients With Colorectal Cancer (Summary Last Modified 04/2002). Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MSKCC-96025, BMS-MSKCC-96025, NCI-V96-0942, NCT00002801
17.	Combination Chemotherapy In Treating Patients With Advanced Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067112, P30CA022453, WSU-D-1641, WSU-04-28-98-M02-FB, NCI-G99-1526, NCT00003925
18.	Combination Chemotherapy in Treating Patients With Advanced Solid Tumors Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068412, PCI-98013, PCI-IRB-990923, NCI-G00-1902, NCT00009815
19.	Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000068413, PCI-98012, PCI-IRB-990929, NCI-G00-1903, NCT00009828
20.	Study of Identification of Prognostic Factors in Patients With Curatively Resected Stage II Colon Cancer Receiving Adjuvant Chemotherapy With Tegafur-Uracil. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Closed Age: 20 to 80 Sponsor: Other Protocol IDs: TMDU-BRI-CC-05-02, BRI-CC-05-02, NCT00898846